ERBB2 and breast cancer: Only H (Hasebe et al., 1996) revealed that the HER-2 protein significantly overexpressed in the breast cancer with moderate and high fibrosis in FF (90.9% vs. 41.7%, n = 153, P <0.02) , compared with the breast cancer with mild fibrosis in FF.